3518 POSTER Cetuximab with Irinotecan/FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomized multicenter AIO phase II study
2007 ◽
Vol 5
(4)
◽
pp. 264
◽
Keyword(s):
Phase Ii
◽